This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

PRoFESS trial

Authoring team

The PRoFESS trial (1) compared the efficacy of two treatments in secondary prevention of stroke:

  • 25 mg aspirin (ASA) and 200 mg extended-release dipyridamole twice a day, with
  • 75 mg clopidogrel once a day

Both regimens resulted in similar rates of recurrent stroke.

Reference:

1. Diener HC et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct;7(10):875-84.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.